Pankaj Mohan Insider Profile

4 Followers
Pankaj Mohan, Director, Ten Percent Owner at Outlook Therapeutics, holds 62.57K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN), holds 7.68M shares in Outlook Therapeutics (Ticker: OTLK).
tipranks
Pankaj Mohan

Pankaj Mohan
Outlook Therapeutics (OTLK)
Director, Ten Percent Owner

Ranked #95,159 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 5 Profitable Transactions

Average Return

-73.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$49M
99.57%
0.43%
A breakdown of Pankaj Mohan's holdings

Insider Roles

Outlook Therapeutics
(OTLK)
Director, Ten Percent Owner
Sonnet BioTherapeutics Holdings
(SONN)
COB, Pres & CEO, Director
Roles that Pankaj Mohan holds in companies

Most Profitable Insider Trade

Stock:
Sonnet BioTherapeutics Holdings
(SONN)
Rating:Informative Buy
Date:Jun 12, 2020 - Jun 12, 2021
Return:-57.20%
The most profitable trade made by Pankaj Mohan

Pankaj Mohan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Outlook Therapeutics
Jan 17, 2019
Director, Ten Percent Owner
Informative Buy
5.44K
$48.56M
Sonnet BioTherapeutics Holdings
Oct 27, 2023
COB, Pres & CEO, Director
Uninformative Buy
$208.36K
List of latest transactions for each holding click on a transaction to see Pankaj Mohan's performance on stock

Pankaj Mohan insider profile FAQ

What is the percentage of profitable transactions made by Pankaj Mohan?
The percentage of profitable transactions made by Pankaj Mohan is 0%.
    What is the average return per transaction made by Pankaj Mohan?
    The average return per transaction made by Pankaj Mohan is -73.00%.
      What stocks does Pankaj Mohan hold?
      Pankaj Mohan holds: OTLK, SONN stocks.
        What was Pankaj Mohan’s latest transaction?
        Pankaj Mohan latest transaction was an Uninformative Buy of ―.
          What was Pankaj Mohan's most profitable transaction?
          Pankaj Mohan’s most profitable transaction was an Informative Buy of SONN stock on June 12, 2020. The return on the trade was -57.20%.
            What is Pankaj Mohan's role in Outlook Therapeutics?
            Pankaj Mohan's role in Outlook Therapeutics is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.